the Onzetra debacle was Rohan's screw up. Rohan had a previous relationship with the Optionse head, and just like that, Avanir launches a 25 year old drug in a generic market place with a delivery device that requires a lot of explaining, and it costs a fortune and doesn't have managed care coverage. Perhaps that is the reason Rohan "resigned." The guy was a moron.